Raiffeisen Bank International’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Raiffeisen Bank International's BMY Position: Q2 2026 in Review
Raiffeisen Bank International reduced its Bristol-Myers Squibb (BMY) stake by 3.2% in Q2 2026, selling an estimated $822K and leaving 432,969 shares worth $25.4M. The position accounts for 0.3% of the portfolio, ranked #80.
Raiffeisen Bank International first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $26.7M in Q1 2026. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Raiffeisen Bank International held 432,969 shares of Bristol-Myers Squibb worth $25.4M as of Q2 2026.
- Raiffeisen Bank International sold 14,315 Bristol-Myers Squibb shares in Q2 2026, an estimated $822K.
- Bristol-Myers Squibb made up 0.3% of Raiffeisen Bank International's portfolio in Q2 2026, its #80 holding.
- Raiffeisen Bank International first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
- Raiffeisen Bank International's Bristol-Myers Squibb position peaked at $26.7M in Q1 2026.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Raiffeisen Bank International's 13F filing for Q2 2026, filed 3 Aug 2026.